Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rubenstein

Showing results (201-210 of 226) with videos related to

Pageof 23
Sort By:
Journal of Drugs in Dermatology : JDD|February 2, 2024
Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic DermatitisLawrence F Eichenfield, Jonathan I Silverberg, Adelaide A Hebert, et al.
Dermatology and Therapy|December 20, 2023
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque PsoriasisLeon Kircik, Matthew Zirwas, Shawn G Kwatra, et al.
Dermatology and Therapy|January 8, 2025
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and ChildrenEric L Simpson, Adelaide A Hebert, John Browning, et al.
Pediatrics|June 3, 2005
Bispectral index as a guide for titration of propofol during procedural sedation among childrenKaren S Powers, Emily B Nazarian, Sarah A Tapyrik, et al.
Pediatrics|September 3, 2004
Duration of mechanical ventilation in life-threatening pediatric asthma: description of an acute asphyxial subgroupFrank A Maffei, Elise W van der Jagt, Karen S Powers, et al.
The Annals of Thoracic Surgery|September 25, 2007
Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgeryJill M Cholette, Jeffrey S Rubenstein, George M Alfieris, et al.
The Journal of Dermatological Treatment|January 12, 2025
Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trialsLinda Stein Gold, James Del Rosso, Benjamin D Ehst, et al.
Lancet (London, England)|March 3, 2018
Death and suffering in Eastern Ghouta, Syria: a call for action to protect civilians and health careSamer Jabbour, Fouad M Fouad, Jennifer Leaning, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2023
Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical reviewJonathan I Silverberg, Mark Boguniewicz, Francisco J Quintana, et al.
Dermatology and Therapy|July 22, 2025
Tapinarof Cream for Adults and Children with Atopic Dermatitis-Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical TrialsAndrew F Alexis, Leon Kircik, Raj Chovatiya, et al.
Pageof 23

Showing results (201-210 of 226) with videos related to

Sort By:
Pageof 23
Journal of Drugs in Dermatology : JDD|February 2, 2024
Targeting the Aryl Hydrocarbon Receptor to Address the Challenges of Atopic DermatitisLawrence F Eichenfield, Jonathan I Silverberg, Adelaide A Hebert, et al.
Dermatology and Therapy|December 20, 2023
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque PsoriasisLeon Kircik, Matthew Zirwas, Shawn G Kwatra, et al.
Dermatology and Therapy|January 8, 2025
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and ChildrenEric L Simpson, Adelaide A Hebert, John Browning, et al.
Pediatrics|June 3, 2005
Bispectral index as a guide for titration of propofol during procedural sedation among childrenKaren S Powers, Emily B Nazarian, Sarah A Tapyrik, et al.
Pediatrics|September 3, 2004
Duration of mechanical ventilation in life-threatening pediatric asthma: description of an acute asphyxial subgroupFrank A Maffei, Elise W van der Jagt, Karen S Powers, et al.
The Annals of Thoracic Surgery|September 25, 2007
Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgeryJill M Cholette, Jeffrey S Rubenstein, George M Alfieris, et al.
The Journal of Dermatological Treatment|January 12, 2025
Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trialsLinda Stein Gold, James Del Rosso, Benjamin D Ehst, et al.
Lancet (London, England)|March 3, 2018
Death and suffering in Eastern Ghouta, Syria: a call for action to protect civilians and health careSamer Jabbour, Fouad M Fouad, Jennifer Leaning, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2023
Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical reviewJonathan I Silverberg, Mark Boguniewicz, Francisco J Quintana, et al.
Dermatology and Therapy|July 22, 2025
Tapinarof Cream for Adults and Children with Atopic Dermatitis-Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical TrialsAndrew F Alexis, Leon Kircik, Raj Chovatiya, et al.
Pageof 23